Cambrex to Exhibit and Present at InformexUSA 2010
East Rutherford, NJ – Cambrex Corporation (NYSE: CBM, "Cambrex") will be exhibiting its products, and its capabilities in drug delivery and custom development and manufacturing services at InformexUSA 2010, February 16-19 in San Francisco, CA. In addition, Cambrex personnel will give two presentations at the Informex Technology Showcase on February 16.
The Informex event is highly regarded as the fine, specialty and custom chemistry showcase of innovative technology and quality products and services. Cambrex will be exhibiting its capabilities in Controlled Substances, High Potency/Cytotoxics, Highly Energetic Chemistries, Biocatalysis/Biotransformation and Chiral Synthesis in addition to its Polymeric Drug Delivery and Custom Development and Manufacturing Services.
The Informex Technology Showcase on February 16 provides exhibiting companies the opportunity to present their latest developments in technologies and services. In Cambrex’s first presentation, Dr. Mark Maier will present an innovative approach to determining occupational control limits for safely handling highly potent compounds. Cambrex’s approach utilizes in vitro testing that allows for a more accurate determination of exposure limits, thus providing better risk management while saving both time and money in the development of active pharmaceutical ingredients and intermediates.
In the second Technology Showcase, Dr. Jayne E. Muir will speak about Cambrex’s Continuous Flow Microwave Assisted Organic Synthesis (CF-MAOS) technology. The CF-MAOS dual technological breakthrough, which won the Silver Innovation award at CPhI 2009, allows both the scale-up of microwave-assisted chemistry and the handling of heterogeneous mixtures in a continuous-flow arrangement. Cambrex’s current technology, the CaMWave™ KiloLAB flow reactor, is capable of manufacturing over 20 kilograms of product per day. Further, the Company is developing larger reactors that have the potential to manufacture more than one hundred metric tons of product per year. This technology facilitates faster, cleaner, more reliable scale-up leading to improved productivity and lower manufacturing costs.
Cambrex will exhibit at booth 1628 in the Moscone Center during InformexUSA.
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.